...
首页> 外文期刊>Journal of Molecular Liquids >Mixed micellization of bile salts and transglycosylated stevia and enhanced binding and solubility of non-steroidal anti-inflammatory drugs using mixed micelle
【24h】

Mixed micellization of bile salts and transglycosylated stevia and enhanced binding and solubility of non-steroidal anti-inflammatory drugs using mixed micelle

机译:混合胶束化胆汁盐和转蛋白化的甜叶菊和非甾体抗炎药用混合胶束增强的结合和溶解性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This research investigated the efficacy of mixed micellar systems as an innovative chemical means of improving the binding properties of poorly water-soluble drugs. The formulations based on the mole fraction were used to prepare mixed micelles using anionic sodium deoxycholate (NaDC) or sodium cholate (NaC), and nonionic transglycosylated stevia (Stevia-G). Surface tension and dynamic light scattering (DLS) assessed the characteristic of the NaDC-Stevia-G and NaC-Stevia-G mixed micelles. Rubingh approach evaluated the interaction parameter (-beta(m)), which demonstrated synergistic interaction between the anionic and non-ionic surfactant. Mixed micelle was used to assess the binding constant (K-b) and solubility of non-steroidal anti-inflammatory drugs, ethenzamide (ETZ), and ibuprofen (IBF). K-b values increased, but the mean occupancy (I) of ETZ and IBF per micelle decreased by increasing as, alpha(Stevia-G )0.1 to 0.9, predicting a shift in occupancy of drugs from Palisade to Stem layer. At alpha(Stevia-G) 0.9 the maximum solubility of ETZ and IBF was 7.50 and 2.60 mmolL(-1) for NaDC-Stevia-G and 5.60 and 1.70 mmolL(-1) for NaC-Stevia-G. To get a better comprehension about micellization behavior and preferential interaction of the drugs under study, quantum chemical calculations and molecular dynamic (MD) simulations were performed. The MD analysis assessed that the poorly water-soluble drugs demonstrated strong binding in the presence of NaDC-Stevia-G as compared to NaC-Stevia-G mixed micelle. Ultimately, in pharmaceutical applications, mixed micelle of bile salts-Stevia-G can be used as an effective drug solubilizing agent. (C) 2020 Elsevier B.V. All rights reserved.
机译:本研究调查了混合胶束系统作为改善水溶性差的药物结合特性的创新化学方法的疗效。使用基于摩尔馏分的制剂使用阴离子脱氧胆酸钠(NADC)或胆酸钠(NAC)和非离子胰糖基化甜叶酸(Stevia-G)制备混合胶束。表面张力和动态光散射(DLS)评估了NADC-Stevia-G和NAC-甜叶菊混合胶束的特征。鲁布希方法评估了相互作用参数(-beta(m)),其在阴离子和非离子表面活性剂之间表现出协同相互作用。混合胶束用于评估非甾体抗炎药,乙苯胺(ETZ)和布洛芬(IBF)的非甾体抗炎药的结合常数(K-B)和溶解度。 K-B值增加,但通过增加Anα(甜菊酰基)0.1至0.9,预测从俯仰到茎层的药物占据占用的转变,因此eTZ和IBF的平均占用(I)降低。在α(甜叶菊)0.9 NAC-Stevia-G和5.60和1.70 mmoll(-1)的ETZ和IBF的最大溶解度为7.50和2.60 mmoll(-1),用于NAC-甜菊-G。为了更好地理解胶束化行为和研究中药物的优先相互作用,进行量子化学计算和分子动态(MD)模拟。 MD分析评估了与Nac-Stevia-G混合胶束相比,水溶性药物较差的药物在NADC-Stevia-G存在下表现出强烈的结合。最终,在药物应用中,胆汁盐 - 甜叶菊的混合胶束可用作有效的药物溶解剂。 (c)2020 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号